Bloomberg Business

AstraZeneca, Sanofi RSV Drug for Infants Wins CDC Backing

A drug from AstraZeneca Plc and Sanofi to protect infants against a potentially fatal respiratory illness won backing Thursday from US public health advisers, moving it closer to being administered alongside other childhood immunizations.

Sweden’s SBB Weighs IPO of $3.4 Billion Residential Unit

SBB, the embattled developer at the center of Sweden’s property crisis, is considering carving out its entire residential business with a portfolio of 36.5 billion kronor ($3.4 billion) for an initial public offering, according to a person familiar with the matter.

IMF Pins Ethiopia Funding Program on Debt-Restructuring Progress

Ethiopia’s long-awaited International Monetary Fund program requires clear commitments from development partners and financing assurances from creditors on the nation’s debt-restructuring plan for funding to be approved, the Washington-based lender said.

Close Bitnami banner
Bitnami